![](https://i1.wp.com/hrnxt.com/wp-content/uploads/2020/10/Drreddys.jpg?resize=200%2C112&ssl=1)
Dr. Reddy’s Laboratories Ltd., and Russian Direct Investment Fund (RDIF) announced that they have commenced adaptive phase 2/3 clinical trials for Sputnik V vaccine in India after receiving the necessary clearance from the Central Drugs Laboratory, Kasauli, India. This will be a multicenter and randomized controlled study, which will include safety and immunogenicity study, Dr.…